Breaking News Instant updates and real-time market news.

SMFG

Sumitomo Mitsui

$7.10 /

+0.055 (+0.78%)

08:15
01/29/20
01/29
08:15
01/29/20
08:15

Sumitomo Mitsui initiated with a Buy at Jefferies

Jefferies analyst Hideyasu Ban initiated coverage of Sumitomo Mitsui with a Buy rating and 5,100 yen price target.

TODAY'S FREE FLY STORIES

Recommendations
Domino's Pizza price target lowered to $316 from $335 at Wells Fargo » 08:55
03/31/20
03/31
08:55
03/31/20
08:55
DPZ

Domino's Pizza

$344.71 /

+6.26 (+1.85%)

Wells Fargo analyst Jon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon Pharmaceuticals expects cash to fund operations into 2022 » 08:55
03/31/20
03/31
08:55
03/31/20
08:55
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Notable open interest changes for March 31st » 08:55
03/31/20
03/31
08:55
03/31/20
08:55
AAPL

Apple

$254.79 /

+7.05 (+2.85%)

, BAC

Bank of America

$22.03 /

+0.44 (+2.04%)

, MSFT

Microsoft

$160.31 /

+10.65 (+7.12%)

, BA

Boeing

$152.25 /

-9.755 (-6.02%)

Monday's total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon Pharmaceuticals says no change to previous guidance on FX301 » 08:55
03/31/20
03/31
08:55
03/31/20
08:55
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

, FLXN

Flexion

$8.21 /

+ (+0.00%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
U.S. equities have moved lower » 08:55
03/31/20
03/31
08:55
03/31/20
08:55

U.S. equities have moved…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Tabula Rasa HealthCare resilient in face of COVID-19, says Baird » 08:54
03/31/20
03/31
08:54
03/31/20
08:54
TRHC

Tabula Rasa HealthCare

/

+

Baird analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
CUI Global price target raised to $3 from $2 at Lake Street » 08:54
03/31/20
03/31
08:54
03/31/20
08:54
CUI

CUI Global

$0.95 /

+0.0899 (+10.45%)

Lake Street analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon Pharmaceuticals says no change to previous guidance on NBI-921352 » 08:54
03/31/20
03/31
08:54
03/31/20
08:54
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

, NBIX

Neurocrine

$91.69 /

+3.07 (+3.46%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon Pharmaceuticals expects results from Phase 2 study of XEN007 in 2020 » 08:53
03/31/20
03/31
08:53
03/31/20
08:53
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Legacy Housing price target lowered to $14 from $21 at Lake Street » 08:52
03/31/20
03/31
08:52
03/31/20
08:52
LEGH

Legacy Housing

$9.86 /

-0.13 (-1.30%)

Lake Street analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
MasterCard price target lowered to $325 from $370 at Wells Fargo » 08:52
03/31/20
03/31
08:52
03/31/20
08:52
MA

MasterCard

$252.83 /

+5.35 (+2.16%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon expects FDA feedback on Phase 3 trial design for XEN496 in 2Q20 » 08:52
03/31/20
03/31
08:52
03/31/20
08:52
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Visa price target lowered to $205 from $230 at Wells Fargo » 08:51
03/31/20
03/31
08:51
03/31/20
08:51
V

Visa

$165.53 /

+4.06 (+2.51%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon expects topline data for XEN1101 Phase 2b trial in 1H21 » 08:50
03/31/20
03/31
08:50
03/31/20
08:50
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Rebalancing put on hold in some cases, according to Bloomberg » 08:50
03/31/20
03/31
08:50
03/31/20
08:50

Rebalancing put on hold…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Tesla would be prudent to lower delivery guidance, says Baird » 08:49
03/31/20
03/31
08:49
03/31/20
08:49
TSLA

Tesla

$501.85 /

-12.955 (-2.52%)

Baird analyst Ben Kallo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Federal Reserve announces establishment of temporary FIMA repo facility » 08:49
03/31/20
03/31
08:49
03/31/20
08:49
SPY

SPDR S&P 500 ETF Trust

$261.57 /

+8.18 (+3.23%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

The Federal Reserve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon seeing significant reduction in enrollment for XEN1101 Phase 2b trial » 08:49
03/31/20
03/31
08:49
03/31/20
08:49
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Monolithic Power price target lowered to $190 from $200 at Needham » 08:49
03/31/20
03/31
08:49
03/31/20
08:49
MPWR

Monolithic Power

/

+

Needham analyst N. Quinn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Dollar General upgraded to Overweight at Wells Fargo amid COVID-19 crisis » 08:49
03/31/20
03/31
08:49
03/31/20
08:49
DG

Dollar General

$146.61 /

+0.49 (+0.34%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon Pharmaceuticals expects cash to fund operations into 2022 » 08:48
03/31/20
03/31
08:48
03/31/20
08:48
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

Xenon Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
AMN Healthcare upgraded to Buy from Neutral at Sidoti » 08:47
03/31/20
03/31
08:47
03/31/20
08:47
AMN

AMN Healthcare

$52.22 /

+3.95 (+8.18%)

Sidoti analyst Mitra…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Neogen acquires assets of Magiar Chilenam for undisclosed amount » 08:47
03/31/20
03/31
08:47
03/31/20
08:47
NEOG

Neogen

$66.49 /

+7.83 (+13.35%)

Neogen announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Harley-Davidson settles with activist Impala, gives fund one board seat » 08:47
03/31/20
03/31
08:47
03/31/20
08:47
HOG

Harley-Davidson

$17.91 /

+0.105 (+0.59%)

Harley-Davidson disclosed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
FDANews to hold a webinar » 08:47
03/31/20
03/31
08:47
03/31/20
08:47

Webinar entitled,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.